📋 Tender Overview
Innovative, Minimally Invasive Device To Support The Natural Movement Of The Heart In Heart Failure Patients
Minimally Invasive Technology For Heart Failure Patientsrecent Studies Have Shown That The Scooping, Longitudinal Movement Of The Mitral Valve Is Crucial For The Heart To Pump Enough Blood For The Body’S Metabolic Needs. This Movement Is Weakened In Heart Failure. To Address This Issue, The Eu-Funded Heart Function Support Project Proposes The Syntach Cs Device, A Ground-Breaking Technology That Can Provide Long-Term Cardiac Support By Restoring The Natural Function Of The Mitral Plane Movement In Patients Suffering From Left Ventricular Heart Failure. The Device Is Fully Implantable And Minimally Invasive And Is Synchronised With The Heart To Support And Re-Establish A Natural, Healthy Cardiac Movement. It Can Be Wirelessly Monitored And Recharged, With No External Elements Protruding Through The Skin, Making It A Life-Saving Solution For Heart Failure Patients.
Funded Under
The European Innovation Council (Eic)
Total Cost
€ 25 695 814,00
Eu Contribution
€ 2 500 000,00
Coordinated By
Syntach Ab
Sweden
Start Date
1 September 2022
End Date
31 March 2027
Objective
Syntach CS is a groundbreaking, life-saving device for long-term cardiac support that restores the natural function of the heart’s mitral plane movement in patients suffering from left ventricular heart failure. The technology is based on recent findings of the physiological movement of
the intact heart, which pumps with a scooping, longitudinal movement of the mitral valve. In heart failure, this movement is impaired and the heart is unable to pump enough blood to meet the metabolic needs of the body. Syntach CS works in synchronization with the heart, supports the cardiac
movements and reestablishes a natural, healthy movement. It is fully implantable in a minimally invasive procedure. Heart movement support is enabled thanks to a mitral anchor ring connected to a drive unit implanted in the lower apex region of the heart from which a pulsatile movement is
transferred to the mitral plane. The system is recharged and monitored wirelessly with no elements protruding through the skin.
